Literature DB >> 26553234

SPRINT Trial Results: Latest News in Hypertension Management.

William C Cushman1, Paul K Whelton1, Lawrence J Fine1, Jackson T Wright1, David M Reboussin1, Karen C Johnson1, Suzanne Oparil1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26553234      PMCID： PMC4768735          DOI： 10.1161/HYPERTENSIONAHA.115.06722

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  5 in total

Review 1.  Measurement of blood pressure in the office: recognizing the problem and proposing the solution.

Authors:  Martin G Myers; Marshall Godwin; Martin Dawes; Alexander Kiss; Sheldon W Tobe; Janusz Kaczorowski
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

2.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Walter T Ambrosius; Kaycee M Sink; Capri G Foy; Dan R Berlowitz; Alfred K Cheung; William C Cushman; Lawrence J Fine; David C Goff; Karen C Johnson; Anthony A Killeen; Cora E Lewis; Suzanne Oparil; David M Reboussin; Michael V Rocco; Joni K Snyder; Jeff D Williamson; Jackson T Wright; Paul K Whelton
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

Review 4.  Diabetes and hypertension: the bad companions.

Authors:  Ele Ferrannini; William C Cushman
Journal:  Lancet       Date:  2012-08-11       Impact factor: 79.321

5.  Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Authors:  Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112
  5 in total
  30 in total

1.  Hypertension Treatment ACCORDing to SPRINT.

Authors:  Karla Campos; Samar Sheth; Stephanie A Coulter
Journal:  Tex Heart Inst J       Date:  2016-08-01

Review 2.  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.

Authors:  Pantelis A Sarafidis; Antonios A Lazaridis; Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Nat Rev Endocrinol       Date:  2017-01-20       Impact factor: 43.330

3.  Exploring Predictors of Information Use to Self-Manage Blood Pressure in Midwestern African American Women with Hypertension.

Authors:  Lenette M Jones; Tiffany Veinot; Susan J Pressler; Patricia Coleman-Burns; Alecia McCall
Journal:  J Immigr Minor Health       Date:  2018-06

Review 4.  BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

Authors:  Hemal Bhatt; Lama Ghazi; David Calhoun; Suzanne Oparil
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

Review 5.  Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.

Authors:  Elvira O Gosmanova; Csaba P Kovesdy
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

6.  Opportunities for the Advanced Practice Nurse to Enhance Hypertension Knowledge and Self-management Among African American Women.

Authors:  Lenette M Jones; Marie-Anne S Rosemberg; Kathy D Wright
Journal:  Clin Nurse Spec       Date:  2017 Nov/Dec       Impact factor: 1.067

Review 7.  Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.

Authors:  Gemma Currie; Christian Delles
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

Review 8.  The optimal blood pressure target in diabetes mellitus: a quest coming to an end?

Authors:  Eirini Papadopoulou; Elena Angeloudi; Spiridon Karras; Pantelis Sarafidis
Journal:  J Hum Hypertens       Date:  2018-06-22       Impact factor: 3.012

9.  Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.

Authors:  Kathleen Dungan; Timothy E Craven; Kyaw Soe; Jackson T Wright; Jan Basile; William E Haley; Nancy R Kressin; Uzma Rani; Leonardo Tamariz; Jeff Whittle; Alan Wiggers; Kwame Osei
Journal:  Diabetes Obes Metab       Date:  2017-11-09       Impact factor: 6.577

Review 10.  Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients.

Authors:  Gennaro Russo; Ilaria Liguori; Luisa Aran; Giulia Bulli; Francesco Curcio; Gianluigi Galizia; Gaetano Gargiulo; Gianluca Testa; Andrea Ungar; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  J Hum Hypertens       Date:  2018-07-10       Impact factor: 3.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.